Where you are today
Your current market position, portfolio, evidence base and commercial setup in Germany.
Germany Market Entry Navigator
The Germany Market Entry Navigator is a short self-assessment of your readiness across clinical validation, market access and commercial execution. It helps identify the questions that should be resolved before committing to a German launch model.
The Navigator is a starting point. Product-specific German market decisions require clinical, access and commercial validation. See the full MedTech market entry in Germany route.
The route
You do not need every stage. The Navigator identifies which stages matter for your situation and prioritises them into one plan.
Your current market position, portfolio, evidence base and commercial setup in Germany.
What is missing across market access, KOL engagement, distribution, positioning and evidence — and what matters most.
Reimbursement pathway, pricing signal, payer and stakeholder mapping, and the route into the German healthcare system.
KOL engagement, advisory boards and the clinical evidence needed to support adoption and coverage.
Distributor search and qualification, reference-centre development and hospital access.
Local market representation, sales execution and commercial operations delivered in Germany.
Wider hospital adoption, additional evidence and commercial expansion — a route that holds.
Fix Germany · Germany Commercial Diagnostic
The Germany Commercial Diagnostic identifies the causes behind weak distributor sales, few hospital customers, unclear positioning, reimbursement issues, pricing problems or low KOL engagement — and recommends a concrete go-to-market reset.
Situation review
Current position, targets, distributor setup and evidence base.
Gap analysis
Market access, KOL engagement, distribution, positioning and pricing.
Root-cause diagnosis
Why adoption and revenue are below expectation.
Go-to-market reset
Prioritised actions to rebuild traction in Germany.
Next step